In their Interim Management Statement for the nine-month period to the end of September, Glanbia announced an upgrade in full-year guidance for earnings per share (EPS) from 17% to 20%.
Glanbia Performance Nutrition (GPN) drove a like-for-like branded revenue increase of 3%, which reflected a price increase of 8.9%, offsetting a volume decline of 5.9%.
Glanbia Nutritionals – Nutritional Solutions recorded a like-for-like revenue decline of 14%, with volume down 6.4% and price down 7.6%.
ADVERTISEMENT
Volume decline
The drop in volume was caused by supply chain rebalancing in the earlier part of the year, with growth returning in the third quarter. Dairy market price falls contributed to a decline in the value of sales.
The performance nutrition side of the business is expected to deliver strong performance in the fourth quarter, increasing year-to-date revenue growth of 2.7% on a constant currency basis to 5% for the full year.
EBITDA margins are expected to be between 14% and 14.5% for the 2023 year.
It is less positive on the Nutritional Solutions side of the business – a “low double-digit decline in like-for-like revenue driven by lower dairy market pricing and a mid-single digit volume decline” is expected, with EBITDA margins between 12% and 13%.
Register for free to read this story and our free stories.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
In their Interim Management Statement for the nine-month period to the end of September, Glanbia announced an upgrade in full-year guidance for earnings per share (EPS) from 17% to 20%.
Glanbia Performance Nutrition (GPN) drove a like-for-like branded revenue increase of 3%, which reflected a price increase of 8.9%, offsetting a volume decline of 5.9%.
Glanbia Nutritionals – Nutritional Solutions recorded a like-for-like revenue decline of 14%, with volume down 6.4% and price down 7.6%.
Volume decline
The drop in volume was caused by supply chain rebalancing in the earlier part of the year, with growth returning in the third quarter. Dairy market price falls contributed to a decline in the value of sales.
The performance nutrition side of the business is expected to deliver strong performance in the fourth quarter, increasing year-to-date revenue growth of 2.7% on a constant currency basis to 5% for the full year.
EBITDA margins are expected to be between 14% and 14.5% for the 2023 year.
It is less positive on the Nutritional Solutions side of the business – a “low double-digit decline in like-for-like revenue driven by lower dairy market pricing and a mid-single digit volume decline” is expected, with EBITDA margins between 12% and 13%.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS